<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03113656</url>
  </required_header>
  <id_info>
    <org_study_id>17-008</org_study_id>
    <nct_id>NCT03113656</nct_id>
  </id_info>
  <brief_title>Weighted Blankets With Infants With NAS</brief_title>
  <official_title>The Use of Weighted Blankets in the Care of Infants With Neonatal Abstinence Syndrome (NAS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TriHealth Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TriHealth Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infants with neonatal abstinence syndrome (NAS) who are cared for in a Neonatal Intensive
      Care Unit (NICU) often display symptoms including hyperactivity, irritability, jitteriness,
      poor feeding, and poor sleep patterns. The recommended first line of treatment to relieve
      these symptoms involves nonpharmacological interventions. The purpose of the current pilot
      study is to provide preliminary data to assist in the design of a larger scale study to
      examine one nonpharmacological intervention, weighted blankets. The pilot study will assess
      the feasibility of a cross-over randomized controlled design to study the impact of a
      weighted blanket on infants' symptoms of NAS.

      The aims of the study are:

      Aim1: To determine the feasibility of recruiting patients for a study evaluating the use of
      weighted blankets in the care of infants with NAS Aim 2: To determine the feasibility and
      safety of the study procedures Aim 3: To examine whether there is clinical benefit to using
      weighted blankets for the treatment of symptoms in infants with NAS.

      After informed consent is obtained, infants will be randomized to have either a weighted
      blanket or a non-weighted blanket placed on them first. A cross-over design will be used so
      all infants will experience both the non-weighted and weighted blankets. Thirty minutes
      before each feeding, baseline vital signs and Finnegan score will be obtained. Then, a
      blanket (weighted or non-weighted) will be placed on the infant for 30 minutes. Infants will
      be directly monitored and on heart rate/respiratory rate monitors while the blanket is
      applied. Vital signs and Finnegan scores will be obtained at the end of 30 minutes of blanket
      placement, infants will be fed, and vital signs and Finnegan scores will be obtained again 30
      minutes after the blanket was removed. Descriptive statistics will be used to determine the
      enrollment rate and feasibility of the protocol. Nonparametric statistics will be used to
      compare total Finnegan scores for infants with the weighted blanket applied compared to
      infants with a non-weighted blanket applied. Changes in Finnegan scores will be examined to
      estimate an effect size to use in a power analysis for a future larger effectiveness study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 14, 2017</start_date>
  <completion_date type="Actual">January 18, 2018</completion_date>
  <primary_completion_date type="Actual">December 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Finnegan Score</measure>
    <time_frame>baseline and 30 minutes</time_frame>
    <description>Finnegan scale measures signs of neonatal drug withdrawal syndrome. It provides a summative score obtained from the assessment of 21 items related to neonatal withdrawal. The total score ranges from 0 to 43 with a higher score indicating more severe symptoms. Values above 8 have been described as being indicative of neonatal abstinence syndrome.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Neonatal Abstinence Syndrome</condition>
  <arm_group>
    <arm_group_label>Weighted Blanket First</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive the Weighted Blanket first and then the Non-weighted blanket</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-weighted Blanket First</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive the Non-weighted Blanket first and then the Weighted blanket</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Weighted Blanket</intervention_name>
    <description>Weighted blanket placed on infant for 30 minutes</description>
    <arm_group_label>Non-weighted Blanket First</arm_group_label>
    <arm_group_label>Weighted Blanket First</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-Weighted Blanket</intervention_name>
    <description>Non-Weighted blanket placed on infant for 30 minutes</description>
    <arm_group_label>Non-weighted Blanket First</arm_group_label>
    <arm_group_label>Weighted Blanket First</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admitted to the NICU

          -  Gestational age &gt; 37 weeks

          -  Positive maternal drug screen at delivery

        Exclusion Criteria:

          -  Clinical staff does not give permission to enroll the patient

          -  Had intrauterine growth restriction (IUGR)

          -  Has any medical diagnosis in addition to NAS diagnosis

          -  Has a weight below the 10th percentile
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>37 Weeks</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>April 10, 2017</study_first_submitted>
  <study_first_submitted_qc>April 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2017</study_first_posted>
  <results_first_submitted>April 12, 2019</results_first_submitted>
  <results_first_submitted_qc>August 14, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">September 19, 2019</results_first_posted>
  <last_update_submitted>August 14, 2019</last_update_submitted>
  <last_update_submitted_qc>August 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>TriHealth Inc.</investigator_affiliation>
    <investigator_full_name>Rachel Baker</investigator_full_name>
    <investigator_title>Nurse Researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neonatal Abstinence Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 25, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/56/NCT03113656/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Weighted Blanket First</title>
          <description>This group will receive the Weighted Blanket first and then the Non-weighted blanket
Weighted Blanket: Weighted blanket placed on infant for 30 minutes
Non-Weighted Blanket: Non-Weighted blanket placed on infant for 30 minutes</description>
        </group>
        <group group_id="P2">
          <title>Non-weighted Blanket First</title>
          <description>This group will receive the Non-weighted Blanket first and then the Weighted blanket
Weighted Blanket: Weighted blanket placed on infant for 30 minutes
Non-Weighted Blanket: Non-Weighted blanket placed on infant for 30 minutes</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Weighted Blanket First</title>
          <description>This group will receive the Weighted Blanket first and then the Non-weighted blanket
Weighted Blanket: Weighted blanket placed on infant for 30 minutes
Non-Weighted Blanket: Non-Weighted blanket placed on infant for 30 minutes</description>
        </group>
        <group group_id="B2">
          <title>Non-weighted Blanket First</title>
          <description>This group will receive the Non-weighted Blanket first and then the Weighted blanket
Weighted Blanket: Weighted blanket placed on infant for 30 minutes
Non-Weighted Blanket: Non-Weighted blanket placed on infant for 30 minutes</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="7"/>
            <count group_id="B3" value="16"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.89" spread="8.24"/>
                    <measurement group_id="B2" value="4.00" spread="3.06"/>
                    <measurement group_id="B3" value="5.63" spread="6.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Finnegan Score</title>
        <description>Finnegan scale measures signs of neonatal drug withdrawal syndrome. It provides a summative score obtained from the assessment of 21 items related to neonatal withdrawal. The total score ranges from 0 to 43 with a higher score indicating more severe symptoms. Values above 8 have been described as being indicative of neonatal abstinence syndrome.</description>
        <time_frame>baseline and 30 minutes</time_frame>
        <population>Reporting Arms/Groups &quot;per intervention&quot;</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Weighted Blanket: Weighted blanket placed on infant for 30 minutes</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Non-Weighted Blanket: Non-Weighted blanket placed on infant for 30 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Finnegan Score</title>
          <description>Finnegan scale measures signs of neonatal drug withdrawal syndrome. It provides a summative score obtained from the assessment of 21 items related to neonatal withdrawal. The total score ranges from 0 to 43 with a higher score indicating more severe symptoms. Values above 8 have been described as being indicative of neonatal abstinence syndrome.</description>
          <population>Reporting Arms/Groups &quot;per intervention&quot;</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.5167" spread="2.251"/>
                    <measurement group_id="O2" value="-0.2549" spread="1.787"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During entire hospitalization (ranged from 1 day to 15 days)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Intervention</title>
          <description>Weighted Blanket: Weighted blanket placed on infant for 30 minutes</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Non-Weighted Blanket: Non-Weighted blanket placed on infant for 30 minutes</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Nurse Researcher</name_or_title>
      <organization>TriHealth</organization>
      <phone>513-569-6191</phone>
      <email>Rachel_Baker2@trihealth.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

